vs
Alector, Inc.（ALEC）与Axil Brands, Inc.（AXIL）财务数据对比。点击上方公司名可切换其他公司
Axil Brands, Inc.的季度营收约是Alector, Inc.的1.3倍（$8.1M vs $6.2M），Axil Brands, Inc.同比增速更快（5.2% vs -88.5%），Axil Brands, Inc.自由现金流更多（$906.4K vs $-184.1M），过去两年Axil Brands, Inc.的营收复合增速更高（12.1% vs -37.4%）
Alector是一家临床阶段生物制药企业，专注于神经退行性疾病的免疫疗法研发，管线覆盖阿尔茨海默病、额颞叶痴呆、帕金森病等未被满足的医疗需求，主要在美国运营，与全球药企合作推进候选药物的临床试验。
Axil Brands是一家总部位于美国的专业消费电子企业，主营高端听力防护设备、音频增强装置及个性化音频配件，旗下产品涵盖定制耳塞、运动蓝牙耳机等，面向全球普通消费者及专业作业群体销售。
ALEC vs AXIL — 直观对比
营收规模更大
AXIL
是对方的1.3倍
$6.2M
营收增速更快
AXIL
高出93.7%
-88.5%
自由现金流更多
AXIL
多$185.0M
$-184.1M
两年增速更快
AXIL
近两年复合增速
-37.4%
损益表 — Q4 FY2025 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $6.2M | $8.1M |
| 净利润 | — | $704.9K |
| 毛利率 | — | 68.1% |
| 营业利润率 | — | 11.1% |
| 净利率 | — | 8.7% |
| 营收同比 | -88.5% | 5.2% |
| 净利润同比 | -1696.9% | 11.2% |
| 每股收益（稀释后） | — | $0.09 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ALECAXIL
| Q4 25 | $6.2M | $8.1M | ||
| Q3 25 | $3.3M | $6.9M | ||
| Q2 25 | $7.9M | $5.8M | ||
| Q1 25 | $3.7M | $6.9M | ||
| Q4 24 | $54.2M | $7.7M | ||
| Q3 24 | $15.3M | $5.9M | ||
| Q2 24 | $15.1M | $6.5M | ||
| Q1 24 | $15.9M | $6.5M |
净利润ALECAXIL
| Q4 25 | — | $704.9K | ||
| Q3 25 | $-34.7M | $334.3K | ||
| Q2 25 | $-30.5M | $-245.6K | ||
| Q1 25 | $-40.5M | $576.7K | ||
| Q4 24 | $-2.1M | $633.7K | ||
| Q3 24 | $-42.2M | $-109.8K | ||
| Q2 24 | $-38.7M | $49.5K | ||
| Q1 24 | $-36.1M | $781.1K |
毛利率ALECAXIL
| Q4 25 | — | 68.1% | ||
| Q3 25 | — | 67.6% | ||
| Q2 25 | — | 70.0% | ||
| Q1 25 | — | 71.7% | ||
| Q4 24 | — | 71.1% | ||
| Q3 24 | — | 71.0% | ||
| Q2 24 | — | 71.5% | ||
| Q1 24 | — | 71.5% |
营业利润率ALECAXIL
| Q4 25 | — | 11.1% | ||
| Q3 25 | -1153.6% | 6.0% | ||
| Q2 25 | -433.6% | 0.8% | ||
| Q1 25 | -1216.5% | 8.4% | ||
| Q4 24 | -13.4% | 8.7% | ||
| Q3 24 | -315.7% | -2.4% | ||
| Q2 24 | -302.4% | 2.6% | ||
| Q1 24 | -275.0% | -1.6% |
净利率ALECAXIL
| Q4 25 | — | 8.7% | ||
| Q3 25 | -1063.4% | 4.9% | ||
| Q2 25 | -387.7% | -4.3% | ||
| Q1 25 | -1101.6% | 8.3% | ||
| Q4 24 | -3.8% | 8.2% | ||
| Q3 24 | -275.2% | -1.9% | ||
| Q2 24 | -256.4% | 0.8% | ||
| Q1 24 | -227.0% | 12.1% |
每股收益（稀释后）ALECAXIL
| Q4 25 | — | $0.09 | ||
| Q3 25 | $-0.34 | $0.04 | ||
| Q2 25 | $-0.30 | $-0.03 | ||
| Q1 25 | $-0.41 | $0.07 | ||
| Q4 24 | $-0.02 | $0.08 | ||
| Q3 24 | $-0.43 | $-0.02 | ||
| Q2 24 | $-0.40 | $0.11 | ||
| Q1 24 | $-0.38 | $0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $256.0M | $5.0M |
| 总债务越低越好 | $10.0M | $138.3K |
| 股东权益账面价值 | $30.6M | $11.1M |
| 总资产 | $293.2M | $16.2M |
| 负债/权益比越低杠杆越低 | 0.33× | 0.01× |
8季度趋势，按日历期对齐
现金及短期投资ALECAXIL
| Q4 25 | $256.0M | $5.0M | ||
| Q3 25 | $291.1M | $4.1M | ||
| Q2 25 | $307.3M | $4.8M | ||
| Q1 25 | $354.6M | $4.7M | ||
| Q4 24 | $413.4M | $5.2M | ||
| Q3 24 | $457.2M | $4.1M | ||
| Q2 24 | $503.3M | $3.3M | ||
| Q1 24 | $562.1M | $4.9M |
总债务ALECAXIL
| Q4 25 | $10.0M | $138.3K | ||
| Q3 25 | — | $139.2K | ||
| Q2 25 | — | $140.2K | ||
| Q1 25 | — | $141.0K | ||
| Q4 24 | $10.0M | $143.3K | ||
| Q3 24 | — | $144.3K | ||
| Q2 24 | — | $146.6K | ||
| Q1 24 | — | — |
股东权益ALECAXIL
| Q4 25 | $30.6M | $11.1M | ||
| Q3 25 | $57.7M | $10.2M | ||
| Q2 25 | $71.2M | $9.7M | ||
| Q1 25 | $94.6M | $9.7M | ||
| Q4 24 | $126.8M | $8.8M | ||
| Q3 24 | $118.9M | $7.9M | ||
| Q2 24 | $150.6M | $7.7M | ||
| Q1 24 | $178.9M | $8.8M |
总资产ALECAXIL
| Q4 25 | $293.2M | $16.2M | ||
| Q3 25 | $335.3M | $15.4M | ||
| Q2 25 | $356.4M | $12.9M | ||
| Q1 25 | $408.3M | $13.0M | ||
| Q4 24 | $468.3M | $13.7M | ||
| Q3 24 | $516.0M | $11.4M | ||
| Q2 24 | $570.7M | $11.0M | ||
| Q1 24 | $635.5M | $12.7M |
负债/权益比ALECAXIL
| Q4 25 | 0.33× | 0.01× | ||
| Q3 25 | — | 0.01× | ||
| Q2 25 | — | 0.01× | ||
| Q1 25 | — | 0.01× | ||
| Q4 24 | 0.08× | 0.02× | ||
| Q3 24 | — | 0.02× | ||
| Q2 24 | — | 0.02× | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-184.0M | $934.8K |
| 自由现金流经营现金流 - 资本支出 | $-184.1M | $906.4K |
| 自由现金流率自由现金流/营收 | -2951.3% | 11.1% |
| 资本支出强度资本支出/营收 | 0.7% | 0.3% |
| 现金转化率经营现金流/净利润 | — | 1.33× |
| 过去12个月自由现金流最近4个季度 | $-326.5M | — |
8季度趋势，按日历期对齐
经营现金流ALECAXIL
| Q4 25 | $-184.0M | $934.8K | ||
| Q3 25 | $-32.5M | $-739.2K | ||
| Q2 25 | $-49.0M | $194.4K | ||
| Q1 25 | $-60.8M | $-169.9K | ||
| Q4 24 | $-55.0M | $1.0M | ||
| Q3 24 | $-50.7M | $897.3K | ||
| Q2 24 | $-62.8M | $-336.6K | ||
| Q1 24 | $-61.3M | $-912.8K |
自由现金流ALECAXIL
| Q4 25 | $-184.1M | $906.4K | ||
| Q3 25 | $-32.5M | $-747.6K | ||
| Q2 25 | $-49.1M | — | ||
| Q1 25 | $-60.8M | $-258.2K | ||
| Q4 24 | $-55.2M | $941.1K | ||
| Q3 24 | $-50.9M | — | ||
| Q2 24 | $-63.1M | $-394.9K | ||
| Q1 24 | $-61.9M | $-922.1K |
自由现金流率ALECAXIL
| Q4 25 | -2951.3% | 11.1% | ||
| Q3 25 | -997.6% | -10.9% | ||
| Q2 25 | -623.0% | — | ||
| Q1 25 | -1655.0% | -3.7% | ||
| Q4 24 | -101.8% | 12.2% | ||
| Q3 24 | -332.1% | — | ||
| Q2 24 | -418.6% | -6.1% | ||
| Q1 24 | -389.3% | -14.3% |
资本支出强度ALECAXIL
| Q4 25 | 0.7% | 0.3% | ||
| Q3 25 | 0.3% | 0.1% | ||
| Q2 25 | 0.1% | — | ||
| Q1 25 | 0.5% | 1.3% | ||
| Q4 24 | 0.3% | 0.9% | ||
| Q3 24 | 1.4% | — | ||
| Q2 24 | 2.2% | 0.9% | ||
| Q1 24 | 3.4% | 0.1% |
现金转化率ALECAXIL
| Q4 25 | — | 1.33× | ||
| Q3 25 | — | -2.21× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -0.29× | ||
| Q4 24 | — | 1.59× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | -6.80× | ||
| Q1 24 | — | -1.17× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ALEC
暂无分部数据
AXIL
| Hearing Enhancement And Protection | $7.8M | 95% |
| Other | $378.9K | 5% |
